-
1
-
-
0002932052
-
Cancer of the head and neck
-
De Vita, V.T., Hellman, S., Rosenberg, S.A. eds. Philadelphia, Lippincott
-
Schantz, S.P.; Harrison, L.B.; Forastiere, A. Cancer of the head and neck. In: De Vita, V.T., Hellman, S., Rosenberg, S.A. eds. Cancer: principles and Practice of Oncology (Philadelphia, Lippincott, 2001), 30, 789-917.
-
(2001)
Cancer: Principles and Practice of Oncology
, vol.30
, pp. 789-917
-
-
Schantz, S.P.1
Harrison, L.B.2
Forastiere, A.3
-
2
-
-
0027921638
-
Head and neck cancer
-
Everett, E.; Vokes, E.E.; Ralph, R.; Weichselbaum, R.R.; Scott, M.; et al. Head and neck cancer (review). N. Engl. J. Med. 1993, 328, 184-194.
-
(1993)
N. Engl. J. Med.
, vol.328
, pp. 184-194
-
-
Everett, E.1
Vokes, E.E.2
Ralph, R.3
Weichselbaum, R.R.4
Scott, M.5
-
3
-
-
0033898259
-
Head and neck cancer: Overview of recent developements and future directions
-
Forastiere, A. Head and neck cancer: overview of recent developements and future directions. Semin. Oncol. 2000, 27, 1-4.
-
(2000)
Semin. Oncol.
, vol.27
, pp. 1-4
-
-
Forastiere, A.1
-
4
-
-
0033892116
-
Treatment of patients with recurrent or metastatic squamous cell carcinoma of the head and neck: Current status and future directions
-
Khuri, F.R.; Shin, D.M.; Glisson, B.S.; Lippman, S.M.; Hong, W.K. Treatment of patients with recurrent or metastatic squamous cell carcinoma of the head and neck: current status and future directions. Sem. Oncol. 2000, 27, 25-33.
-
(2000)
Sem. Oncol.
, vol.27
, pp. 25-33
-
-
Khuri, F.R.1
Shin, D.M.2
Glisson, B.S.3
Lippman, S.M.4
Hong, W.K.5
-
5
-
-
0030065644
-
Chemotherapy for squamous cell carcinoma: The future is now
-
Vokes, E.E.; Athanasiadis, I. Chemotherapy for squamous cell carcinoma: the future is now. Ann. Oncol. 1996, 7, 15-29.
-
(1996)
Ann. Oncol.
, vol.7
, pp. 15-29
-
-
Vokes, E.E.1
Athanasiadis, I.2
-
6
-
-
0002291316
-
Topoisomerase II inhibitors: The epipodophyllotoxins, m-AMSA, and the ellipticine derivates
-
Chabner, B.A., Longo, D.L., Eds., Philadelphia, Lippincott-Raven
-
Pommier, Y.; Fesen, M.R.; Goldwasser, F. Topoisomerase II inhibitors: the epipodophyllotoxins, m-AMSA, and the ellipticine derivates. In: Chabner, B.A., Longo, D.L., Eds., Cancer Chemotherapy and Biotherapy (Philadelphia, Lippincott-Raven, 1996), 435-461.
-
(1996)
Cancer Chemotherapy and Biotherapy
, pp. 435-461
-
-
Pommier, Y.1
Fesen, M.R.2
Goldwasser, F.3
-
7
-
-
0029780802
-
Antitumour treatment: The clinical pharmacology of etoposide: and update
-
Joel, S. Antitumour treatment: the clinical pharmacology of etoposide: and update. Cancer Treat Rev. 1996, 22, 179-221.
-
(1996)
Cancer Treat Rev.
, vol.22
, pp. 179-221
-
-
Joel, S.1
-
8
-
-
0032168167
-
Etoposide: Four decades of development of a topoisomerase II inhibitor
-
Hande, K.R. Etoposide: four decades of development of a topoisomerase II inhibitor. Europ. J. Cancer 1998, 34, 1514-1521.
-
(1998)
Europ. J. Cancer
, vol.34
, pp. 1514-1521
-
-
Hande, K.R.1
-
9
-
-
0026088127
-
Current status of etoposide in the management of small cell lung cancer
-
Johnson, D.H.; Hainsworth, J.D.; Hande, K.R.; Greco, FA. Current status of etoposide in the management of small cell lung cancer. Cancer 1991, 67, 231-244.
-
(1991)
Cancer
, vol.67
, pp. 231-244
-
-
Johnson, D.H.1
Hainsworth, J.D.2
Hande, K.R.3
Greco, F.A.4
-
10
-
-
0025961914
-
New chemotherapies for ovarian cancer
-
Muggia, F.M.; Russel, C.A. New chemotherapies for ovarian cancer. Cancer 1991, 67, 225-230.
-
(1991)
Cancer
, vol.67
, pp. 225-230
-
-
Muggia, F.M.1
Russel, C.A.2
-
11
-
-
0018595465
-
Therapeutic trials with VP-16-213 and VM-26: Active agents in small cell lung cancer, Non-Hodgkin's lymphomas and other malignancies
-
Radice, P.A.; Bunn, P.A.; Ihde, D.C. Therapeutic trials with VP-16-213 and VM-26: active agents in small cell lung cancer, Non-Hodgkin's lymphomas and other malignancies. Cancer Trat. Rep. 1979, 63, 1231-1239.
-
(1979)
Cancer Trat. Rep.
, vol.63
, pp. 1231-1239
-
-
Radice, P.A.1
Bunn, P.A.2
Ihde, D.C.3
-
12
-
-
0026020696
-
Current strategies in the management of locoregional and metastatic gastric carcinoma
-
Ajani, J.A.; Ota, D.M.; Jackson, D.E. Current strategies in the management of locoregional and metastatic gastric carcinoma. Cancer 1991, 67, 260-265.
-
(1991)
Cancer
, vol.67
, pp. 260-265
-
-
Ajani, J.A.1
Ota, D.M.2
Jackson, D.E.3
-
13
-
-
0031753296
-
Treatment of non-small-cell lung cancer with prolonged oral etoposide
-
Oct
-
Kakolyris, S.; Samonis, G.; Koukourakis ,M.; Vlachonicolis, I.; Chalkiadakis, G.; et al. Treatment of non-small-cell lung cancer with prolonged oral etoposide. Oncol. 1998 Oct; 21 (5), 505-508.
-
(1998)
Oncol.
, vol.21
, Issue.5
, pp. 505-508
-
-
Kakolyris, S.1
Samonis, G.2
Koukourakis, M.3
Vlachonicolis, I.4
Chalkiadakis, G.5
-
14
-
-
0028088853
-
Oral etoposide is acitve against platinum-resistent epithelial ovarian cancer
-
Hoskins, P.J.; Swenerton, K.D. Oral etoposide is acitve against platinum-resistent epithelial ovarian cancer. J. Clin. Oncol. 1994, 12, 60-63.
-
(1994)
J. Clin. Oncol.
, vol.12
, pp. 60-63
-
-
Hoskins, P.J.1
Swenerton, K.D.2
-
15
-
-
0026573038
-
Phase II study of single-agent etoposide in patients with metastatic squamous cell carcinoma to the esophagus
-
Harstrick, A.; Bokemeyer, C.; Preusser, P.; Kohne-Womper, C.H.; Meyer, H.J.; et al. Phase II study of single-agent etoposide in patients with metastatic squamous cell carcinoma to the esophagus. Cancer Chemother. Pharmacol. 1992, 29, 321-322.
-
(1992)
Cancer Chemother. Pharmacol.
, vol.29
, pp. 321-322
-
-
Harstrick, A.1
Bokemeyer, C.2
Preusser, P.3
Kohne-Womper, C.H.4
Meyer, H.J.5
-
16
-
-
0037276592
-
Results of phase I-II trial of concomitant hyperfractionated radiation and oral etoposide (VP-16) in patients with unresectable squamous cell carcinoma of the head and neck
-
Khafif, A.; Canfield, V.A.; Syzek, E.J.; Medina, J.E. Results of phase I-II trial of concomitant hyperfractionated radiation and oral etoposide (VP-16) in patients with unresectable squamous cell carcinoma of the head and neck. Am. J. Orolaryngol. 2003, 24, 1-5.
-
(2003)
Am. J. Orolaryngol.
, vol.24
, pp. 1-5
-
-
Khafif, A.1
Canfield, V.A.2
Syzek, E.J.3
Medina, J.E.4
-
17
-
-
0033202261
-
Prognosis after salvage chemotherapy for locally unresectable recurrent squamous cell carcinoma of the head and neck
-
Khono, N.; Kitahara, S.; Kawaida, M.; Ohmuma, T. Prognosis after salvage chemotherapy for locally unresectable recurrent squamous cell carcinoma of the head and neck. Jpn. J. Clin. Oncol. 1999, 29, 462-466.
-
(1999)
Jpn. J. Clin. Oncol.
, vol.29
, pp. 462-466
-
-
Khono, N.1
Kitahara, S.2
Kawaida, M.3
Ohmuma, T.4
-
18
-
-
0019365237
-
Reporting results of cancer treatment
-
Miller, A.B.; Hoogstraten, B.; Staquet, M. Reporting results of cancer treatment. Cancer 1981, 147, 207-214.
-
(1981)
Cancer
, vol.147
, pp. 207-214
-
-
Miller, A.B.1
Hoogstraten, B.2
Staquet, M.3
-
19
-
-
0036380344
-
Phase II study with docetaxel and cisplatin in the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck
-
Gedlicka, C.; Formanek, M.; Selzer, E.; Burian, M.; Kornfehl, J.; et al. Phase II study with docetaxel and cisplatin in the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck. Oncology 2002, 63(2), 145-150.
-
(2002)
Oncology
, vol.63
, Issue.2
, pp. 145-150
-
-
Gedlicka, C.1
Formanek, M.2
Selzer, E.3
Burian, M.4
Kornfehl, J.5
-
20
-
-
0027296903
-
Treatment of elderly patients with small cell lung cancer
-
Keane, M.; Karney, D.N. Treatment of elderly patients with small cell lung cancer. Lung Cancer 1993, 9 (suppl 1), 91-98.
-
(1993)
Lung Cancer
, vol.9
, Issue.1 SUPPL.
, pp. 91-98
-
-
Keane, M.1
Karney, D.N.2
-
21
-
-
8244228676
-
A phase II study of mitomycin C and oral etoposide for advanced adenocarcinoma of the upper gastrointestinal tract
-
Braybrooke, J.P.; O'Byrne, K.J.; Saunders, M.P.; Propper, D.J.; Salisbury, A.J.; et al. A phase II study of mitomycin C and oral etoposide for advanced adenocarcinoma of the upper gastrointestinal tract. Ann. Oncol. 1997, 8, 294-296.
-
(1997)
Ann. Oncol.
, vol.8
, pp. 294-296
-
-
Braybrooke, J.P.1
O'Byrne, K.J.2
Saunders, M.P.3
Propper, D.J.4
Salisbury, A.J.5
-
22
-
-
0022348146
-
Phase II trial of oral VP16-213 (etoposide) in patients with advanced head and neck cancer
-
Oct 31
-
Crivellari, D.; Veronesi, A.; Magri, M.D.; Tirelli, U.; Comoretto, R.; et al. Phase II trial of oral VP16-213 (etoposide) in patients with advanced head and neck cancer. Tumori. 1985 Oct 31; 71 (5), 499-500.
-
(1985)
Tumori.
, vol.71
, Issue.5
, pp. 499-500
-
-
Crivellari, D.1
Veronesi, A.2
Magri, M.D.3
Tirelli, U.4
Comoretto, R.5
-
23
-
-
0022412687
-
Phase II study of etoposide (VP-16) in the treatment of advanced head and neck cancer
-
Oct
-
Grunberg, S.M.; Felman, I.E.; Gala, K.V.; Johnson, K.B.; Owens, J.C. Phase II study of etoposide (VP-16) in the treatment of advanced head and neck cancer. Am. J. Clin. Oncol. 1985 Oct; 8 (5), 393-395.
-
(1985)
Am. J. Clin. Oncol.
, vol.8
, Issue.5
, pp. 393-395
-
-
Grunberg, S.M.1
Felman, I.E.2
Gala, K.V.3
Johnson, K.B.4
Owens, J.C.5
|